TCL Archive NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers November 21, 1975
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant. August 31, 2001